Myriad Genetics, Inc. (MYGN)
6.06
+0.22
(+3.77%)
USD |
NASDAQ |
Jan 22, 16:00
5.92
-0.14
(-2.31%)
After-Hours: 07:55
Myriad Genetics Cash from Investing (Quarterly): -6.20M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insulet Corp. | -31.00M |
| Neogen Corp. | -11.67M |
| ICU Medical, Inc. | -30.03M |
| Intuitive Surgical, Inc. | -- |
| West Pharmaceutical Services, Inc. | -63.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 21.10M |
| Cash from Financing (Quarterly) | 56.20M |
| Free Cash Flow | -29.50M |
| Free Cash Flow Per Share (Quarterly) | 0.16 |
| Free Cash Flow to Equity (Quarterly) | -42.80M |
| Free Cash Flow to Firm (Quarterly) | 18.87M |
| Free Cash Flow Yield | -5.29% |